Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393:169–82.

Article  PubMed  Google Scholar 

Vaccarella S, Franceschi S, Zaridze D, Poljak M, Veerus P, Plummer M, et al. Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study. Lancet Oncol. 2016;17:1445–52.

Article  PubMed  PubMed Central  Google Scholar 

Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA. 2021;71:505–26.

PubMed  PubMed Central  Google Scholar 

Wang W, Jia HL, Huang JM, Liang YC, Tan H, Geng HZ, et al. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br J Cancer. 2014;110:1748–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer. 2013;49:3262–73.

Article  PubMed  Google Scholar 

Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, et al. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci U S A. 2000;97:9543–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scita G, Confalonieri S, Lappalainen P, Suetsugu S. IRSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions. Trends Cell Biol. 2008;18:52–60.

Article  CAS  PubMed  Google Scholar 

Millard TH, Dawson J, Machesky LM. Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties. J Cell Sci. 2007;120:1663–72.

Article  CAS  PubMed  Google Scholar 

Huang LY, Wang YP, Wei BF, Yang J, Wang JQ, Wu BH, et al. Deficiency of IRTKS as an adaptor of insulin receptor leads to insulin resistance. Cell Res. 2013;23:1310–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang L-Y, Wang X, Cui X-F, Li H, Zhao J, Wu C-C, et al. IRTKS is correlated with progression and survival time of patients with gastric cancer. Gut. 2018;67:1400–9.

Article  CAS  PubMed  Google Scholar 

Wang YP, Huang LY, Sun WM, Zhang ZZ, Fang JZ, Wei BF, et al. Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma. Cancer Lett. 2013;337:96–106.

Article  CAS  PubMed  Google Scholar 

Chao A, Tsai CL, Jung SM, Chuang WC, Kao C, Hsu A, et al. BAI1-associated protein 2-like 1 (BAIAP2L1) is a potential biomarker in ovarian cancer. PLoS ONE. 2015;10:e0133081.

Article  PubMed  PubMed Central  Google Scholar 

He M, Wang Y, Cai J, Xie Y, Tao C, Jiang Y, et al. LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway. Exp Cell Res. 2021;402:112551.

Article  CAS  PubMed  Google Scholar 

Zhang X, Zhang Y, Qiu X, Cai J, Yang Z, Song F. Extracellular vesicles derived from lung cancer cells induce transformation of normal fibroblasts into lung cancer-associated fibroblasts and promote metastasis of lung cancer by delivering lncRNA HOTAIR. Stem Cells Int. 2022;2022:3805013.

Article  PubMed  PubMed Central  Google Scholar 

Roy S, Sunkara RR, Parmar MY, Shaikh S, Waghmare SK. EMT imparts cancer stemness and plasticity: new perspectives and therapeutic potential. Front Biosci. 2021;26:238–65.

Article  CAS  Google Scholar 

Hubbard SR. The insulin receptor: both a prototypical and atypical receptor tyrosine kinase. Cold Spring Harb Perspect Biol. 2013;5:a008946.

Article  PubMed  PubMed Central  Google Scholar 

Vingadassalom D, Kazlauskas A, Skehan B, Cheng HC, Magoun L, Robbins D, et al. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A. 2009;106:6754–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu Y, Zhou XY, Zhou CL, Liu J, Yong T, Fan Y, et al. Insulin receptor tyrosine kinase substrate (IRTKS) promotes the tumorigenesis of pancreatic cancer via PI3K/AKT signaling. Hum Cell. 2022;35:1885–99.

Article  CAS  PubMed  Google Scholar 

Deng N, Zhang X, Zhang Y. BAIAP2L1 accelerates breast cancer progression and chemoresistance by activating AKT signaling through binding with ribosomal protein L3. Cancer Sci. 2022;114:764.

Article  PubMed  PubMed Central  Google Scholar 

Xu L, Du H, Zhang Q, Wang C, Yan L, Tian G, et al. BAI1-associated protein 2-like 2 is a potential biomarker in lung cancer. Oncol Rep. 2019;41:1304–12.

CAS  PubMed  Google Scholar 

Ding X, Jia X, Wang C, Xu J, Gao SJ, Lu C. A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer. Cell Death Differ. 2019;26:1750–65.

Article  CAS  PubMed  Google Scholar 

Lu W, Kang Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev Cell. 2019;49:361–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu A, Wang X, Luo J, Zhou M, Yi R, Huang T, et al. Overexpressed P75CUX1 promotes EMT in glioma infiltration by activating β-catenin. Cell Death Dis. 2021;12:157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Guo S, Kim SJ, Shao F, Ho JWK, Wong KU, et al. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel. Theranostics. 2021;11:2442–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S, Cong X, Gao H, Lan X, Li Z, Wang W, et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res. 2019;38:6.

Article  PubMed  PubMed Central  Google Scholar 

Derynck R, Weinberg RA. EMT and cancer: more than meets the eye. Dev Cell. 2019;49:313–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009;69:7135–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suzuki HI. MicroRNA control of TGF-β signaling. Int J Mol Sci. 2018;19:1901.

Article  PubMed  PubMed Central  Google Scholar 

Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011;208:875–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008;68:7846–54.

Article  CAS